Skip to main content

Table 1 Effects of acetazolamide (ACZ) on radiologic and clinical metrics in patients with iNPH

From: MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic Normal Pressure Hydrocephalus

ID

Age

Gender

Days between scans

Ventricle vol. (mm 3 )

Cortical thickness

T1 hypo. vol (mm 3 )

CBF (ml/100 ml/min)

Symmetrized % change

Boon score

Improvement

Before

After

mm

z-score

Before

After

Before

MD

f 0

CBF

Before

After

ACZ_1

90

Male

83

125,124

124,758

2.08

−0.1

13,653

12,087

13.2

9.2

6

35

10

10

yes

ACZ_2

72

Female

143

77,447

76,605

2.02

−1.7

19,073

11,782

25.9

8.5

5.7

21

10

6

yes

ACZ_3

86

Male

86

123,287

122,220

2.09

−0.2

16,508

13,891

27.2

7

4.5

16

17

12

yes

ACZ_4*

80

Female

99

148,137

146,563

2.29

0.2

78,730

70,205

17.2

6.6

3

22

10

8/15*

yes

ACZ_5

76

Male

112

163,105

165,388

2.42

1.7

13,930

13,196

15.8

4.1

2.4

17

12

4

yes

ACZ_6

82

Female

93

104,325

105,244

2.20

0.0

7,714

8,525

33.7

−1.6

−1

−9.6

12

14

no

ACZ_7

79

Male

136

176,078

176,778

1.99

−1.7

21,785

14,282

16.8

9.6

3.9

19

20

16

yes

ACZ_8

79

Female

111

111,200

109,500

2.23

0.1

23,437

19,114

20.6

10.4

9.6

2.9

11

9

yes

  1. *The patient suffered a stroke after the reported MRI scans. Her Boon score initially improved, but then worsened after the stroke.
  2. CBF = cerebral blood flow; f 0  = isotropic diffusion fraction [20]; MD = mean diffusivity.